SAB Biotherapeutics Inc banner

Wall St Price Targets

SABS Price Forecast
Based on 13 analysts

+283% Upside
from $3.2 today

SAB Biotherapeutics Inc (SABS)’s 12-month stock price forecast through October 2027 has a consensus target of $12.24, implying 283% upside. The forecast is based on price targets from 13 Wall Street analysts.

SABS Analyst Rating
Based on 11 analysts

avg. 4.91 of 5
Strong buy
10 91%
Buy
1 9%
Hold
0 0%
Sell
0 0%
Strong sell
0 0%

Analysts rate SABS Strong buy, with 11 of 11 recommending Buy or Strong buy.

SAB Biotherapeutics Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SABS's stock price target?
Price Target
12.24 USD

According to Wall Street analysts, the average 1-year price target for SABS is 12.24 USD with a low forecast of 6.06 USD and a high forecast of 16.8 USD.

Back to Top